Alternative splicing of LSD1+8a in neuroendocrine prostate cancer is mediated by SRRM4

[1]  A. Jemal,et al.  Cancer statistics, 2020 , 2020, CA: a cancer journal for clinicians.

[2]  P. Nelson,et al.  Molecular profiling stratifies diverse phenotypes of treatment-refractory metastatic castration-resistant prostate cancer. , 2019, The Journal of clinical investigation.

[3]  T. Graeber,et al.  Pan-cancer Convergence to a Small-Cell Neuroendocrine Phenotype that Shares Susceptibilities with Hematological Malignancies. , 2019, Cancer cell.

[4]  Laura M. Heiser,et al.  BET bromodomain inhibition blocks the function of a critical AR-independent master regulator network in lethal prostate cancer , 2019, Oncogene.

[5]  Laura M. Heiser,et al.  Maintenance of MYC expression promotes de novo resistance to BET bromodomain inhibition in castration-resistant prostate cancer , 2019, Scientific Reports.

[6]  James C. Hu,et al.  The Gene Ontology Resource: 20 years and still GOing strong , 2019 .

[7]  M. Gleave,et al.  SRRM4 gene expression correlates with neuroendocrine prostate cancer , 2018, The Prostate.

[8]  Yuxin Tang,et al.  A novel mechanism of SRRM4 in promoting neuroendocrine prostate cancer development via a pluripotency gene network , 2018, EBioMedicine.

[9]  Joshua M. Stuart,et al.  Clinical and Genomic Characterization of Treatment-Emergent Small-Cell Neuroendocrine Prostate Cancer: A Multi-institutional Prospective Study. , 2018, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  William H. Bisson,et al.  LSD1 activates a lethal prostate cancer gene network independently of its demethylase function , 2018, Proceedings of the National Academy of Sciences.

[11]  A. Zoubeidi,et al.  Cellular plasticity and the neuroendocrine phenotype in prostate cancer , 2018, Nature Reviews Urology.

[12]  K. Tanabe,et al.  Overexpression of Transmembrane Protein BST2 is Associated with Poor Survival of Patients with Esophageal, Gastric, or Colorectal Cancer , 2017, Annals of Surgical Oncology.

[13]  Astrid Gall,et al.  Ensembl 2018 , 2017, Nucleic Acids Res..

[14]  C. Collins,et al.  Establishment of a neuroendocrine prostate cancer model driven by the RNA splicing factor SRRM4 , 2017, Oncotarget.

[15]  Qiuyue Wang,et al.  TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer , 2017, Oncotarget.

[16]  Qiuyue Wang,et al.  TRIM22 confers poor prognosis and promotes epithelial-mesenchymal transition through regulation of AKT/GSK3β/β-catenin signaling in non-small cell lung cancer , 2017, Oncotarget.

[17]  Wenlin Huang,et al.  BST2 confers cisplatin resistance via NF-κB signaling in nasopharyngeal cancer , 2017, Cell Death & Disease.

[18]  P. Nelson,et al.  LuCaP Prostate Cancer Patient‐Derived Xenografts Reflect the Molecular Heterogeneity of Advanced Disease and Serve as Models for Evaluating Cancer Therapeutics , 2017, The Prostate.

[19]  Kenji Suzuki,et al.  LSD1/KDM1 isoform LSD1+8a contributes to neural differentiation in small cell lung cancer , 2016, Biochemistry and biophysics reports.

[20]  N. Landsberger,et al.  LSD1 Neurospecific Alternative Splicing Controls Neuronal Excitability in Mouse Models of Epilepsy. , 2015, Cerebral cortex.

[21]  P. Nelson,et al.  SRRM4 Expression and the Loss of REST Activity May Promote the Emergence of the Neuroendocrine Phenotype in Castration-Resistant Prostate Cancer , 2015, Clinical Cancer Research.

[22]  M. Esteller,et al.  Identification of HERC5 and its potential role in NSCLC progression , 2015, International journal of cancer.

[23]  B. Garcia,et al.  A specific LSD1/KDM1A isoform regulates neuronal differentiation through H3K9 demethylation. , 2015, Molecular cell.

[24]  E. Ben-Jacob,et al.  Prostate Cancer and Neuroendocrine Differentiation: More Neuronal, Less Endocrine? , 2015, Front. Oncol..

[25]  R. Darnell,et al.  Microexons—Tiny but mighty , 2015, The EMBO journal.

[26]  Matthew E. Ritchie,et al.  limma powers differential expression analyses for RNA-sequencing and microarray studies , 2015, Nucleic acids research.

[27]  W. Huber,et al.  Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2 , 2014, Genome Biology.

[28]  Jernej Ule,et al.  A global regulatory mechanism for activating an exon network required for neurogenesis. , 2014, Molecular cell.

[29]  P. Nelson,et al.  Overexpression of IFN-induced protein with tetratricopeptide repeats 3 (IFIT3) in pancreatic cancer: cellular “pseudoinflammation” contributing to an aggressive phenotype , 2014, Oncotarget.

[30]  Shanhong Tang,et al.  [Significance of SAMD9 expression in esophageal squamous cell carcinoma]. , 2014, Xi bao yu fen zi mian yi xue za zhi = Chinese journal of cellular and molecular immunology.

[31]  M. Tortorici,et al.  Phosphorylation of neuronal Lysine‐Specific Demethylase 1LSD1/KDM1A impairs transcriptional repression by regulating interaction with CoREST and histone deacetylases HDAC1/2 , 2014, Journal of neurochemistry.

[32]  M. Rubin,et al.  High fidelity patient-derived xenografts for accelerating prostate cancer discovery and drug development. , 2014, Cancer research.

[33]  S. Ye,et al.  BST-2 is a potential activator of invasion and migration in tamoxifen-resistant breast cancer cells. , 2013, Biochemical and biophysical research communications.

[34]  Sean R. Davis,et al.  NCBI GEO: archive for functional genomics data sets—update , 2012, Nucleic Acids Res..

[35]  Bernd Fritzsch,et al.  A Mutation in the Srrm4 Gene Causes Alternative Splicing Defects and Deafness in the Bronx Waltzer Mouse , 2012, PLoS genetics.

[36]  Qun Pan,et al.  Cross-regulation between an alternative splicing activator and a transcription repressor controls neurogenesis. , 2011, Molecular cell.

[37]  Colin N. Dewey,et al.  RSEM: accurate transcript quantification from RNA-Seq data with or without a reference genome , 2011, BMC Bioinformatics.

[38]  Klaus Pantel,et al.  Cell-free nucleic acids as biomarkers in cancer patients , 2011, Nature Reviews Cancer.

[39]  J. C. Belmonte,et al.  LSD1 regulates the balance between self-renewal and differentiation in human embryonic stem cells , 2011, Nature Cell Biology.

[40]  Y. Kaneda,et al.  Sterile alpha motif containing domain 9 is involved in death signaling of malignant glioma treated with inactivated Sendai virus particle (HVJ‐E) or type I interferon , 2010, International journal of cancer.

[41]  F. Forneris,et al.  Alternative Splicing of the Histone Demethylase LSD1/KDM1 Contributes to the Modulation of Neurite Morphogenesis in the Mammalian Nervous System , 2010, The Journal of Neuroscience.

[42]  Jie Cao,et al.  Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis , 2009, BMC Cancer.

[43]  Pablo Tamayo,et al.  Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profiles , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[44]  Hubert Vesselle,et al.  Phenotypic heterogeneity of end-stage prostate carcinoma metastatic to bone. , 2003, Human pathology.

[45]  M. Ashburner,et al.  Gene Ontology: tool for the unification of biology , 2000, Nature Genetics.

[46]  C. Collins,et al.  SRRM4 Drives Neuroendocrine Transdifferentiation of Prostate Adenocarcinoma Under Androgen Receptor Pathway Inhibition. , 2017, European urology.

[47]  Alex E. Lash,et al.  Gene Expression Omnibus: NCBI gene expression and hybridization array data repository , 2002, Nucleic Acids Res..